Latest News About - MRSA
Tools
Sunday, December 9, 2018
8:05:00 PM CET
Language Selection
For any category/filter, users can choose:
- the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
- the language of the user interface (e.g. it for Italian)
In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)
Country Selection
Users can choose:
- country mentioned in the news item (articles about a country)
- country in which the news item was published (articles from a country)
Languages 
Select your languages
Interface:
Most reported countries (24h)
AlertLevel (24h)
Previous 14 days average
Alert level:
high
medium
low
Extracted quotes
César de la Fuente said: “We think this new antibiotic we generated, inspired by nature, it’s a promising candidate,” 
bostonherald Saturday, December 8, 2018 12:34:00 AM CET
Gail Hansen said: "This really does move the ball quite a bit,"
MaltaIndipendent Friday, December 7, 2018 5:18:00 AM CET
Scott Taylor said: "You're going to see more stuff like that in the future,"
MaltaIndipendent Friday, December 7, 2018 5:18:00 AM CET
Sanjay Jain said: "We used to think we could just give a drug and patients should get better," "Now, we have tools to measure the nuances that make a difference. PET could be used to study other antibiotics and also allow precision medicine approaches in resource-rich settings, such as the U.S. for other serious infections including MRSA (methicillin-resistant Staphylococcus aureus)"
upi Thursday, December 6, 2018 9:58:00 PM CET
Sanjay Jain says: "We used to think we could just give a drug and patients should get better," "Now, we have tools to measure the nuances that make a difference. PET could be used to study other antibiotics and also allow precision medicine approaches in resource-rich settings, such as the U.S. for other serious infections including MRSA (methicillin-resistant Staphylococcus aureus)"
eurekalert Thursday, December 6, 2018 5:12:00 PM CET
Jose Bengoechea explains: “As the antibiotics we currently use are inefficient at targeting bacteria that live inside our cells, this finding has important clinical implications on how we treat Klebsiella infections,”
ec-europa Thursday, December 6, 2018 12:15:00 PM CET
Jose Bengoechea says: “What we see is a close relationship between Klebsiella’s antibiotic resistance and its virulence, or ability to infect a resistant host,” “These findings emphasise the importance of evaluating both antibiotic resistance and virulence in order to better monitor a patient’s outcome”
ec-europa Thursday, December 6, 2018 12:15:00 PM CET
Jose Bengoechea adds: “I believe this host-directed therapeutic approach will limit the pathogen’s ability to develop resistance against new treatments,” “We already obtained very promising results in animal models in which, without the need for antibiotics, we were able to reduce the infection by more than 80 %”
ec-europa Thursday, December 6, 2018 12:15:00 PM CET
Jose Bengoechea explains: “Interferons activate macrophages and natural killer cells to control Klebsiella pneumonia,” “What this finding means is that interferons could be considered for new therapeutics developments”
ec-europa Thursday, December 6, 2018 12:15:00 PM CET
Jose Bengoechea concludes: “Although we are still at the very early stages, these potential new treatments will have a major health impact, especially considering the increasing number of Klebsiella infections worldwide and the limited treatment options available,”
ec-europa Thursday, December 6, 2018 12:15:00 PM CET
Jeffrey Klausner reports: “We used a similar test at UCLA in Los Angeles and found that doctors liked the test and were much more likely to prescribe a safer and simpler medicine like oral Cipro tablets instead of using injections like Ceftriaxone,”
euroinvestor Thursday, December 6, 2018 9:47:00 AM CET
Jeffrey Klausner adds: “If more doctors use the ResistancePlus GC assay, patients will have a better choice when it comes to treatment and we might make a big difference in controlling antibiotic resistant gonorrhea,”
euroinvestor Thursday, December 6, 2018 9:47:00 AM CET
David Macdonald said: "Our new facility creates the perfect space for us to showcase our products and create a work environment for employees that promotes innovation, collaboration, and fun,"
marketwatch Wednesday, December 5, 2018 5:14:00 PM CET
James Hayward stated: “This Analyst Day webinar serves as an excellent platform from which to build awareness for LineaRx’s competitive advantages and user benefits to the biotherapeutics industry at large. Anyone currently utilizing plasmid DNA and/or virus to transduce cells, in the DNA/RNA vaccine space, involved in CRISPR as well as, CAR-T Therapy could benefit greatly from our technology,”
marketwatch Tuesday, December 4, 2018 11:03:00 PM CET
Nedret Emiroglu told: "We need financial support for low and middle-income countries,"
globalissues Tuesday, December 4, 2018 5:47:00 PM CET
Marc Keller betont: „Mit dem System von SpinDiag wird Gesundheitseinrichtungen ein standardisierter, effizienter und ökonomischer Screening-Prozess zur Verfügung stehen, der die Patientensicherheit transparent in den Mittelpunkt stellt“
idw-online Tuesday, December 4, 2018 11:36:00 AM CET
Sam Shepard explica: «Staphlococcus epidermidis es un patógeno mortal a simple vista»
abc-Andalucia Wednesday, November 28, 2018 4:13:00 PM CET
Jesper Larsen siger: »Det problematiske ved det er, at tarP -genet i princippet så også kan hoppe over på helt andre typer stafylokokker. Indtil videre har vi kun set det i de to MRSA-kloner CC-398 og CC-5, men der kan sagtens være andre typer, der har fået tarP -genet,«
ing Monday, November 26, 2018 3:55:00 PM CET
Jesper Larsen siger: »Fremtidige forsøg på at lave vacciner rettet mod stafylokokkernes overfladestruktur er nødt til at tage højde for den ekstra overfladestruktur. Ellers vil vaccinen ikke dække alle typer stafylokokker,«
ing Monday, November 26, 2018 3:55:00 PM CET
Jesper Larsen siger: - Det her er absolut noget, vi vil holde øje med. Vi ved ikke, hvad der kommer til at ske, hvis det spreder sig til andre MRSA-typer, men vi kan frygte, at MRSA-sygdomsbyrden så vil blive øget,
DRNyheder Saturday, November 24, 2018 7:08:00 AM CET
Jesper Larsen siger: - Så er der risiko for, at det tager længere tid for kroppen at bekæmpe de infektioner,
DRNyheder Saturday, November 24, 2018 7:08:00 AM CET
Jesper Larsen siger: - Flere forsøger at udvikle en generel vaccine mod MRSA. Men de er nødt til at være opmærksomme på den her evne, for ellers risikerer de, at vaccinen ikke beskytter bredt,
DRNyheder Saturday, November 24, 2018 7:08:00 AM CET
Jesper Larsen siger: ”MRSA-bakteriernes evne til at gemme sig for vores immunsystem er et problem, fordi vores immunsystem spiller en afgørende rolle i bekæmpelsen af infektioner”
ssi Friday, November 23, 2018 6:24:00 AM CET
Oliver Sonntag afirma: "Além da aplicação médica, que requer um exame intensivo, focamo-nos na vida quotidiana"
prnewswire Tuesday, November 20, 2018 1:49:00 PM CET
Oliver Sonntag afirma: "Após o desenvolvimento de revestimentos não aderentes invisíveis, como os revestimentos cerâmicos 9H, e revestimentos de autolimpeza ou super-hidrofóbicos, os revestimentos autodesinfetantes constituem o passo seguinte lógico e consequente, anunciando uma nova era de revestimentos invisíveis"
prnewswire Tuesday, November 20, 2018 1:49:00 PM CET
Paul Johnson řekl: „Výskyt MRSA (multirezistentní zlatý stafylokok) v našich nemocnicích výrazně poklesl, což bylo skvělé, jelikož pacientům se dařilo daleko lépe a potlačilo se tak riziko závažných infekcí,“
novinky Saturday, August 25, 2018 6:16:00 PM CEST
Most associated names
Daily number of articles in this category
Trend data not available for this selection.
Most active sources for this category
Contact: 